These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36609388)

  • 21. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar.
    Bener A; Al-Hamaq AO
    Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):504-511. PubMed ID: 27023007
    [No Abstract]   [Full Text] [Related]  

  • 24. Global Challenges in Access to and Implementation of Precision Oncology: The Health Care Manager and Health Economist Perspective.
    Shih YT; Pan IW; Teich N
    Am Soc Clin Oncol Educ Book; 2022 Jul; 42():429-437. PubMed ID: 35829692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study.
    Zia N; Ibrahim MIM; Adheir F; Babar ZU
    BMJ Open; 2021 Nov; 11(11):e054150. PubMed ID: 34819289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discussing uncertainty and risk in primary care: recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening.
    Wilkes M; Srinivasan M; Cole G; Tardif R; Richardson LC; Plescia M
    J Gen Intern Med; 2013 Nov; 28(11):1410-9. PubMed ID: 23649782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
    Cowie MR; Bozkurt B; Butler J; Briggs A; Kubin M; Jonas A; Adler AI; Patrick-Lake B; Zannad F
    Int J Cardiol; 2022 Oct; 365():61-68. PubMed ID: 35905826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual health services.
    Schnell-Inderst P; Hunger T; Hintringer K; Schwarzer R; Seifert-Klauss VR; Gothe H; Wasem J; Siebert U
    GMS Health Technol Assess; 2011; 7():Doc05. PubMed ID: 21966301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Precision Health and Nursing Care in the Digital Age].
    Lee BO
    Hu Li Za Zhi; 2022 Apr; 69(2):4-6. PubMed ID: 35318626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of antimicrobial stewardship programs within governmental hospitals in Qatar: a SWOC analysis.
    Nasr ZG; Jibril F; Elmekaty E; Sonallah H; Chahine EB; AlNajjar A
    Int J Pharm Pract; 2021 Feb; 29(1):70-77. PubMed ID: 33793820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
    Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
    J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
    [No Abstract]   [Full Text] [Related]  

  • 34. AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).
    Todorovic V; Aapro M; Pavlidis N; Arsovski O; Belkacemi Y; Babovic N; Bidard FC; Bourhafour M; Beslija S; Boussen H; Cetnikovic B; Ceric T; Cicmil N; Crnogorac N; Cuedari E; De Laurentis M; Dragovich T; Durutovic I; Dzamic Z; Dzodic R; Eri Z; Geara F; Khalil A; Kerrou K; Knezevic Usaj S; Kovcin V; Koroveshi D; Kristo Pema A; Kuten A; Lakicevic J; Lukovac N; Markovic I; Markovic M; Mijalkovic N; Miladinova D; Milasevic N; Mustachi G; Ognjenovic D; Pantelic A; Popovic L; Radosavljevic D; Radosevic N; Radulovic S; Ristevski M; Rosic I; Secen N; Sorat M; Stamatovic L; Stefanovski P; Stojkovski I; Tesanovic D; Tomasevic Z; Tomasevic Z; Tsoutsou P; Turkan S; Vasev N; Vasovic S; Vicko F; Vrbanec D; Vukmirovic F; Vrdoljak E; Zaric B; Zambrovski JJ; Cavalli F; Gligorov J
    J BUON; 2019; 24(5):2180-2197. PubMed ID: 31786893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concern over cost of and access to cancer treatments: A meta-narrative review of nivolumab and pembrolizumab studies.
    da Veiga CRP; da Veiga CP; Drummond-Lage AP
    Crit Rev Oncol Hematol; 2018 Sep; 129():133-145. PubMed ID: 30097232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).
    Deola S; Guerrouahen BS; Sidahmed H; Al-Mohannadi A; Elnaggar M; Elsadig R; Abdelalim EM; Petrovski G; Gadina M; Thrasher A; Wels WS; Hunger SP; Wang E; Marincola FM; ; Maccalli C; Cugno C
    J Transl Med; 2018 Oct; 16(1):276. PubMed ID: 30305089
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.